Department of Internal Medicine, Iwate Medical University, Morioka, Japan.
Am J Cardiol. 2011 Dec 1;108(11):1564-9. doi: 10.1016/j.amjcard.2011.07.011. Epub 2011 Aug 24.
Elevated plasma B-type natriuretic peptide (BNP) levels have been reported to be related to a high risk for cardiovascular (CV) disease in the general population. However, there has been no accurate determination of the threshold levels of plasma BNP that indicate an increased potential for the development of general CV events (i.e., heart failure, stroke, and myocardial infarction) and the validity of these levels for predicting CV events compared to classic risk markers. To establish gender-specific thresholds of plasma BNP levels associated with increased risk for CV disease in the general population, baseline BNP levels were determined in community-dwelling adults (n = 13,209, mean age 62 ± 10 years,) and CV events in the cohort were captured prospectively. The cohort was divided by deciles of plasma BNP level in each gender. A Cox proportional-hazards model was used to determine the relative hazard ratios among the deciles. In addition, to compare the utility of plasma BNP to the Framingham 10-year risk score for predicting general CV events, receiver-operating characteristic analysis was performed. During follow-up, CV events were identified in 429 patients in the cohort. Compared to the reference decile level (first to fourth), the hazard ratio was significantly increased from the ninth decile in men (greater than approximately 37 pg/ml) and the highest decile in women (greater than approximately 55 pg/ml). The area under the curve generated on receiver-operating characteristic analysis of plasma BNP testing was comparable to that for the Framingham risk scoring system (0.67 vs 0.68 in men, 0.63 vs 0.68 in women; p = NS for both). In conclusion, within a community-based general population with no CV history, plasma BNP levels higher than defined thresholds show increased risk for general CV events, and the predictive ability for CV events occurring within several years may be comparable to that of an established long-standing risk score.
血浆 B 型利钠肽(BNP)水平升高与普通人群心血管(CV)疾病风险增加有关。然而,目前尚无确定血浆 BNP 水平阈值的准确方法,这些阈值表明发生一般 CV 事件(即心力衰竭、中风和心肌梗死)的潜在风险增加,并且这些水平在预测 CV 事件方面相对于经典风险标志物的有效性。为了确定与普通人群 CV 疾病风险增加相关的血浆 BNP 水平的性别特异性阈值,在社区居住的成年人(n = 13209,平均年龄 62 ± 10 岁)中确定了基线 BNP 水平,并前瞻性地捕获了队列中的 CV 事件。该队列按每个性别中血浆 BNP 水平的十分位数进行划分。使用 Cox 比例风险模型确定十分位数之间的相对危险比。此外,为了比较血浆 BNP 与 Framingham 10 年风险评分对预测一般 CV 事件的效用,进行了接收者操作特征分析。在随访期间,队列中有 429 名患者发生 CV 事件。与参考十分位数水平(第一至第四)相比,男性的危险比从第九十分位数显着增加(大于约 37 pg/ml),女性的最高十分位数显着增加(大于约 55 pg/ml)。血浆 BNP 检测的接收者操作特征分析生成的曲线下面积与Framingham 风险评分系统相当(男性为 0.67 与 0.68,女性为 0.63 与 0.68;两者均为 p = NS)。总之,在没有 CV 病史的基于社区的普通人群中,高于定义阈值的血浆 BNP 水平显示出一般 CV 事件风险增加,并且在数年内发生 CV 事件的预测能力可能与既定的长期风险评分相当。